Have questions about AnimalBiome partnerships?
AnimalBiome’s industry partners
Improve the efficacy of your products through an AnimalBiome study
AnimalBiome provided a scientific research study to improve the efficacy of and solidify claim statements for product impact on companion animal gut microbiome health. The study featured subjects from a varied case set for cross-comparison with 30,000 reference points from the AnimalBiome gut health database. Results led to improved formula and veterinarian consultant approval.
Cargill invests in studies to understand microbiome science and how it relates to digestive and skin issues in companion animals to help pets live healthier lives. Cargill’s study investment is intended to help AnimalBiome accelerate new products and insights into pet microbiome modulation research. The study expands scientific demonstrations on how a balanced gut plays a key role in pets’ overall health and longevity, and how an unbalanced microbiome can result in diarrhea, weight problems, skin and immune system issues.
Interested in a partnership study with AnimalBiome?
AnimalBiome’s academic partners
Access the world’s largest database for pet microbiome data to support your research
Case Study: Fecal microbiota transplantation capsule therapy via oral route for combatting atopic dermatitis in dogs
Dr. Kerem Ural, Aydın Adnan Menderes University, Faculty of Veterinary Medicine, Department of Internal Medicine
Given the role of the interaction between gut microbiome with dermatological diseases, namely “gut-skin axis”, the present author proved that gut restoration should alleviate canine atopic dermatitis (CAD), which was the purpose of the study. The present study supports a potential benefit of FMT capsule treatment against CAD. This safe and tolerant treatment modality directed against CAD shifted the gut microbiome composition towards a healthy state for all 8 dogs enrolled.